NCT04784572

Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 393 (estimated)
• Sponsor: Centre hospitalier de Ville-Evrard, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Since psychiatry is still too often confronted with a dichotomy between psyche and soma, the assessment of pain and anxiety at RMI is still rarely done (Willer et al., 1982). The objective of this exploratory study is to evaluate the influence of pharmacological factors (type of injected molecules, injection frequency, injection site, treatment duration, treatment dose, time since last injection) and individual about the pain perceived when injecting antipsychotic therapy (diagnosis, sex, age, weight, duration of illness, level of anxiety, psychiatric and somatic comorbidity, insight). In the future, this study will develop a suitable procedure to limit pain and anxiety during RMI. Taking these dimensions into account will probably allow a better compliance of patients for this type of care, and thus a decrease in the number of relapses in the long term.

Conditions

• Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors

Interventions

Type	Name	Description
OTHER	first injection delay and second injection delay	During the first injection, the patient will make END scale for 5 seconds, EVAF scale for 10 seconds and insight scale for 5 minutes. The second injection the patient will make END scale for 5 seconds and EVAF scale for 10 seconds and then a maintenance.

Timeline

• Start date: 2021-01-22
• Primary completion: 2024-09-30
• Completion: 2024-12-31
• First posted: 2021-03-05
• Last updated: 2024-03-06

Locations

1 site across 1 country: France